Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promote long-term functional recovery in hemiparkinsonian rats

Experimental Neurology

Volumn 151, Issue 2, 1998, Pages 203-214

  Borlongan, Cesario V ^a   Saporta, Samuel ^a   Sanberg, Paul R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

6 Hydroxydopamine; Adrenal chromaffin cells; Asymmetrical motor behaviors; Microcarrier beads; Neural transplantation; Parkinson's disease

Indexed keywords

APOMORPHINE; CATECHOLAMINE; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ADRENAL MEDULLA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; CHROMAFFIN CELL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FETUS CELL; IMMUNOHISTOCHEMISTRY; MALE; MOTOR DYSFUNCTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; RAT;

EID: 17944401279     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6790     Document Type: Article

References (45)

1. Aebischer P., Winn S. R., Galletti P. M. Transplantation of neural tissue in polymer capsules. Brain Res. 448:1988;364-368.
2. Araujo D. M., Cotman C. W. Basic FGF in astroglial, microglial, and neuronal cultures: Characterization of binding sites and modulation of release by lymphokines and trophic factors. J. Neurosci. 12:1992;1668-1678.
3. Arkins S., Rebeiz N., Biragyn A., Resese D. L., Kelley K. W. Murine macrophages express abundant insulin-like growth factor I class I Ea and Eb transcripts. Endocrinology. 133:1993;2334-2343.
4. Barker R., Dunnett S. B. Biology and behavior of intracerebral adrenal transplants in animals and man. Rev. Neurosci. 4:1993;113-146.
5. Bohn M. C., Cupit L., Marciano F., Gash D. M. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science. 237:1987;913-916.
6. Borlongan C. V., Sanberg P. R. Elevated body swing test: A new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism. J. Neurosci. 15:1995;5372-5378.
7. Borlongan C. V., Stahl C. E., Cameron D. F., Saporta S., Freeman T. B., Cahill D. W., Sanberg P. R. CNS immunological modulation of graft survival and rejection. Neurol. Res. 18:1996;297-304.
8. Briers T. W., Desmaretz C., Vanmechelen E. Generation and characterization of mouse microglial cell lines. J. Neuroimmunol. 52:1994;153-164.
9. Chen C. S., Mrksich M., Huang S., Whitesides G. M., Ingber D. E. Geometric Control of Cell Life and Death. Science. 276:1997;1425-1428.
10. Cherksey B. D. Microcarrier pre-adhesion enhances long term survival of adult cells implanted into the mammalian brain. Exp. Neurol. 129:1994;20.
11. Eddleston M., Mucke L. Molecular profile of reactive astrocytes - Implications for their role in neurological disease. Neuroscience. 54:1993;15-36.
12. Elsworth J. D., Brittan M. S., Sladek Jr J. R., Taylor J. R., Zea-Ponce Y., Innis R. B., Redmond Jr D. E., Roth R. H. Survival of a high density of serotonin in neurons in fetal ventral mesencephalon grafted to the striatum of MPTP-treated primates: Implications for neural transplantation in Parkinson's disease. Am. Soc. Neural Transplant. Abstr. 3:1996;46.
13. Emerich D. F., McDermott P., Krueger P., Frydel B., Sanberg P. R., Winn S. R. Polymer-encapsulated PC 12 cells promote recovery of motor function in aged rats. Exp. Neurol. 122:1993;37-47.
14. Emerich D. F., Winn S. R., Christenson L., Palmatier M. A., Gentile F. T., Sanberg P. R. A novel approach to neural transplantation in Parkinson's disease: Use of polymer-encapsulated cell therapy. Neurosci. Biobehav. Rev. 16:1992;437-447.
15. Freed W. J., Cannon-Spoor H. E., Krauthamer E. Intrastriatal adrenal medulla grafts in rats. J. Neurosurg. 65:1986;664-670.
16. Freed W. J., Willingham G., Heim R. C. Effects of adrenal medulla and sciatic nerve co-grafts in rats with substantia nigra lesions. J. Neural Transplant. Plast. 3:1992;159-167.
17. Freed W. J., Poltorak M., Becker J. B. Intracerebral adrenal medulla transplants: Review. Exp. Neurol. 110:1990;139-166.
18. Freeman T. B., Wojak J. C., Brandeis L. Cross-species intracerebral grafting of embryonic swine dopaminergic neurons. Prog. Brain Res. 73:1988;473-477.
19. Freeman T. B., Olanow C. W., Hauser R. A., Nauert G. M., Smith D. A., Borlongan C. V., Sanberg P. R., Holt D. A., Kordower J. H., Vingerhoets F. J. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38:1995;379-388.
20. Karstaedt P. J., Kerasidis H., Pincus J. H., Meloni R., Graham J., Gale K. Unilateral destruction of dopamine pathways increases ipsilateral striatal serotonin turnover in rats. Exp. Neurol. 126:1994;25-30.
21. Kiefer R., Gold R. M., Gehrmann J., Lindholm D., Wekerle H., Kreutzberg G. W. Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis. J. Neurosci. Res. 36:1993;391-398.
22. Kordower J. H., Freeman T. B., Snow B. J., Vingerhoets F. J. G., Mufson E. J., Sanberg P. R., Hauser R. A., Smith D. A., Nauert G. M., Perl D. P., Olanow C. W. Neuropathological evidence of graft survival and striatal reinnervation after transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1995;1118-1124.
23. Landis D. M. D. The early reactions of non-neuronal cells to brain injury. Annual Reviews of Neurosciences. 1994;Annual Reviews, Inc. Palo Alto. p. 133-151.
24. Lindholm D., Castren E., Kiefer R., Zafra F., Thoenen H. Transforming growth factor-beta in the rat brain increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 117:1992;395-400.
25. Lindvall O., Backlund E. O., Farde L., Sedvall G., Freedman R., Hoffer B., Nobin A., Seiger A., Olson L. Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen. Ann. Neurol. 22:1987;457-468.
26. Lu S. Y., Shipley M. T., Norman A. B., Sanberg P. R. Striatal, ventral mesencephalic and cortical transplants into the intact rat striatum: A neuroanatomical study. Exp. Neurol. 113:1991;109-130.
27. Lundberg C., Horellou P., Mallet J., Björklund A. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: Exp. Neurol. 139:1996;39-53.
28. Luthman J., Friedemann M., Bickford P., Olson L., Hoffer B. J., Gerhardt G. A. In vivo. Neuroscience. 52:1993;677-687.
29. Luthman J., Bolioli B., Tsutsumi T., Verhofstad A., Jonsson G. Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat. Brain Res. Bull. 19:1987;269-274.
30. McLaurin J., Almazan G., Williams K., Antel J. P. Immortalization and characterization of rat microglial cells. Neuropathol. Appl. Neurobiol. 21:1995;302-311.
31. Moftaquir A., Langley K., Boutroy M. J. Immunocytochemical localization of NCAM and catecholamine-synthesizing enzymes in rabbit intra- and extra-adrenal chromaffin tissue. Histochem. J. 28:1996;661-669.
32. Nakajima K., Kohsaka S. Functional roles of microglia in the brain. Neurosci. Res. 17:1993;187-203.
33. Nieto-Sampedro M., Whittemore S. R., Needels D. L., Larson L., Cotman C. W. The survival of brain transplants is enhanced by extracts from injured brain. Proc. Natl. Acad. Sci. 81:1984;6250-6254.
34. Nieto-Sampedro M., Lewis E. R., Cotman C. W., Manthorpe M., Skaper S. D., Barbin G., Longo F. M., Varon S. Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science. 217:1982;860-861.
35. Ortega J. D., Sagen J., Pappas G. D. Short-term immunosuppression enhances long-term survival of bovine chromaffin cell xenografts in rat CNS. J. Comp. Neurol. 322:1992;1-12.
36. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1982;Academic Press, New York.
37. Presta M., Urbinati C., Dell'era P., Lauro G. M., Sogos V., Balaci L., Ennas M. G., Gremo F. Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. Int. J. Dev. Neurosci. 13:1995;29-39.
38. Sagen J., Wang H., Tresco P. A., Aebischer P. Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain reducing neuroactive substances. J. Neurosci. 13:1993;2415-2423.
39. Schwartz J. P., Nishiyama N. Neurotrophic factor gene-expression in astrocytes during development and following injury. Brain Res. Bull. 35:1994;403-407.
40. Seniuk N. A., Henderson J. T., Tatton W. G., Roder J. C. Increased CNTF gene expression in process bearing astrocytes following injury is augmented by R(-) deprenyl. J. Neurosci. Res. 37:1994;278-286.
41. Silberstein F. C., Desimone R., Levi G., Aloisi F. Cytokine-regulated expression of platelet derived growth factor gene and protein in cultured human astrocytes. J. Neurochem. 66:1996;1409-1417.
42. Tornatore C., Baker-Cairns B., Yadid G., Hamilton R., Meyers K., Atwood W., Cummins A., Tanner V., Major E. Expression of tyrosine hydroxylase in an immortalized human fetal astrocyte cell line: Cell Transplant. 5:1996;145-163.
43. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behavior. Acta Physiol. Scand. 367:1971;49-66.
44. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. 367:1971;69-93.
45. Weiss C., Cahill A. L., Laslop A., Fischer-Colbrie R., Perlman R. L., Winkler H. Differences in the composition of chromaffin granules in adrenaline and noradrenaline containing cells of bovine adrenal medulla. Neurosci. Lett. 211:1996;29-32.